Neumora Therapeutics (NMRA) Shares Issued (2022 - 2025)

Neumora Therapeutics' Shares Issued history runs 4 years deep, the most recent figure standing at -$59000.0 for Q3 2025.

• In Q3 2025, Shares Issued changed N/A year-over-year to -$59000.0; the TTM figure through Sep 2025 stood at $7.5 million (down 96.75% YoY), while the FY2024 annual figure was $7.5 million, down 96.78% from the prior year.
• Shares Issued was -$59000.0 for Q3 2025 at Neumora Therapeutics, down from $59000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $230.0 million in Q4 2023 to a low of -$1.8 million in Q2 2024.
• Historically, Shares Issued has averaged $23.9 million across 4 years, with a median of $503000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Shares Issued jumped 23035.99% in 2023, then slumped 556.68% in 2024.
• A 4-year view of Shares Issued shows it stood at -$1.0 million in 2022, then surged by 23035.99% to $230.0 million in 2023, then plunged by 96.75% to $7.5 million in 2024, then tumbled by 100.79% to -$59000.0 in 2025.
• The last three Shares Issued figures came in at -$59000.0 (Q3 2025), $59000.0 (Q2 2025), and $7.5 million (Q4 2024), per Business Quant data.